EAU 2018 Bladder Cancer

REVIEW UroToday

Viewing 1-20 of 64 articles

EAU 2018: Molecular and Histopathological Heterogeneity in Muscle-Invasive Bladder Cancer

EAU 2018: The Critically Ill Patient with Locally Advanced Bladder Cancer – Ureterocutaneostomy? YES

EAU 2018: The Critically Ill Patient with Locally Advanced Bladder Cancer – Ureterocutaneostomy? NO

EAU 2018: Optimizing Anesthesia in the Frail Patient with Bladder Cancer: What the Urologist Needs to Know

EAU 2018: Urothelial Cancer – A Year in Highlights

EAU 2018: Clinicopathologic Factors Linked to Intravesical Recurrence after Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma

EAU 2018: Can We Rely on Urinary Markers?

EAU 2018: Instillations in The Upper Tract: Which Technique?

EAU 2018: Challenges in Prevention of Bladder Recurrence

EAU 2018: Now or Never - Realizing the Promise of Precision Oncology for Urothelial Carcinoma

EAU 2018: Does New Molecular Subtyping in Urothelial Cancer Add to Tumor, Nodes and Metastasis

EAU 2018: What You Could Miss at Follow-Up After Radical Cystectomy for Muscle Invasive Bladder Cancer

EAU 2018: What Will We Recommend in 2025 for the Management of Bladder Cancer?

EAU 2018: How to Interpret the Specimen’s Pathology – Radical Cystectomy for Muscle Invasive Bladder Cancer

EAU 2018: Management of Muscle Invasive Bladder Cancer – When Should the Guidelines Be Ignored?

EAU 2018: Who Benefits from Neoadjuvant Chemotherapy and Who Needs Immediate Radical Treatment?

EAU 2018: Who are the Optimal Candidates for Bladder Preservation in Cases of Muscle Invasive Bladder Cancer?

EAU 2018: Utility of Lymph Node Dissection for Clinical Node Negative Upper Tract Urothelial Cell Carcinoma: A Multicenter Study

EAU 2018: 4D Ultrasound Cystoscopy with Fly Through in the Evaluation of Urinary Bladder Tumors: Feasibility and Outcomes

EAU 2018: Latent Viral Infection as a Factor of Unfavorable Prognosis of Bladder Cancer

1
2
3
4